• AeroEclipse II® BAN – Harborview Medical Center Study

    Harborview Medical Center Study – AeroEclipse II® BAN – Reduction of 30 day re-admission rate and COPD LOS

  • News Categories

    Featured Products

     

    • Previous Post : AeroEclipse II<sup>®</sup> BAN Efficiency StudyNext Post : AEROECLIPSE<sup>®</sup> Breath Actuated Nebulizers (BAN)